Funding for this research was provided by:
Peking University People’s Hospital Scientific Research Development Funds (RDY2017-28)
Received: 10 August 2022
Accepted: 17 October 2022
First Online: 4 November 2022
: This study was approved by the institutional review board of Peking University People’s hospital (Approval No. 2022PHB 197-001). We informed all patients included in the trial and obtained their informed consent. This study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: All authors declare no competing interests.